JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRY
1951
DELISTED
Berry Corp
BRY
| $11.2M | ﹤0.01% |
1,184,145
+971,660
| +457% | +$9.09M |
|
1952
NMI Holdings
NMIH
$3.42B
| $11.2M | ﹤0.01% |
336,300
+234,049
| +229% | +$7.31M |
|
1953
Tetra Tech
TTEK
$9.33B
| $11.2M | ﹤0.01% |
647,255
+88,785
| +16% | +$1.54M |
|
|
BBT
1954
Beacon Financial Corp
BBT
$2.71B
| $11.2M | ﹤0.01% |
339,090
+150,107
| +79% | +$4.71M |
|
1955
Qualys
QLYS
$6.78B
| $11.1M | ﹤0.01% |
133,686
-43,027
| -24% | -$3.57M |
|
1956
PUT
Honeywell
HON
$74.2B
| $11.1M | ﹤0.01% |
66,737
-35,013
| -34% | -$5.72M |
|
1957
Baytex Energy
BTE
$3B
| $11.1M | ﹤0.01% |
7,673,478
+1,220,325
| +19% | +$1.51M |
|
1958
CALL
HCA Healthcare
HCA
$89.1B
| $11.1M | ﹤0.01% |
75,000
+50,000
| +200% | +$6.71M |
|
1959
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
| $11M | ﹤0.01% |
96,449
-1,394,211
| -94% | -$158M |
|
|
ARI
1960
Apollo Commercial Real Estate
ARI
$886M
| $11M | ﹤0.01% |
601,302
-56,827
| -9% | -$1.05M |
|
1961
Assurant
AIZ
$13.9B
| $11M | ﹤0.01% |
83,755
+4,409
| +6% | +$567K |
|
1962
CALL
Exelon
EXC
$47B
| $11M | ﹤0.01% |
336,901
| – | – |
|
1963
Bunge Global
BG
$21.7B
| $10.9M | ﹤0.01% |
190,106
+146,009
| +331% | +$8.08M |
|
1964
PUT
DexCom
DXCM
$34.5B
| $10.9M | ﹤0.01% |
+200,000
| New | +$9.49M |
|
|
HSII
1965
DELISTED
Heidrick & Struggles
HSII
| $10.9M | ﹤0.01% |
336,214
+112,260
| +50% | +$3.31M |
|
1966
American Airlines Group
AAL
$9.97B
| $10.9M | ﹤0.01% |
380,813
-835,979
| -69% | -$23.8M |
|
1967
PUT
Charter Communications
CHTR
$18.7B
| $10.9M | ﹤0.01% |
22,500
| – | – |
|
1968
PUT
iShares Silver Trust
SLV
$31.3B
| $10.9M | ﹤0.01% |
653,900
| – | – |
|
1969
Lennox International
LII
$14.5B
| $10.9M | ﹤0.01% |
44,635
-613,034
| -93% | -$152M |
|
1970
Avient
AVNT
$4.23B
| $10.9M | ﹤0.01% |
295,674
-121,015
| -29% | -$3.95M |
|
1971
PUT
Eli Lilly
LLY
$1.08T
| $10.9M | ﹤0.01% |
82,700
-39,300
| -32% | -$4.56M |
|
1972
CALL
BBVA Argentina
BBAR
$3.27B
| $10.9M | ﹤0.01% |
1,950,000
-1,450,000
| -43% | -$5.98M |
|
1973
MBIA
MBI
$262M
| $10.9M | ﹤0.01% |
1,167,970
+475,470
| +69% | +$4.52M |
|
1974
PUT
NIO
NIO
$11.3B
| $10.8M | ﹤0.01% |
2,690,500
-1,458,500
| -35% | -$2.93M |
|
|
EPZM
1975
DELISTED
Epizyme, Inc
EPZM
| $10.8M | ﹤0.01% |
439,403
-39,481
| -8% | -$586K |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.